Pressure BioSciences announced entrance into an exclusive distribution agreement for the People’s Republic of China with PRS International Trade. PRS International prepaid for the entire purchase of 16 Barocycler EXT units for a total of nearly $600,000, with a commitment to purchase additional units and related consumables before the end of 2023. This historic purchase of PBIO‘s original high-pressure technology instruments comes on the back of a surge in purchase orders for all product categories of the Company’s pressure-based instruments and consumables.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PBIO:
- Pressure BioSciences, One World Pharma partner for sports drink development
- iCAD Pressure announces CFO transition, hires SVP, US commercial sales
- Pressure BioSciences reports results from focus group testing of THC Oral Spray
- Pressure BioSciences may achieve ‘highest quarterly revenue ever’ in Q4
- Pressure BioSciences announces shipment of UltraShear nanoemulsion product